First, don’t be too quick to advocate for removal. Before you consider where and by whom the catheter will be removed, there are some other questions that should be addressed. Your answers to these questions may indicate that the catheter should be left in place.
Does this patient continue to require a central venous catheter after considering the remaining length of infusion therapy and its characteristics? Is it possible that the infusion therapy is near the end and it may be discontinued or changed to another route? This will require reading the progress notes of the licensed independent practitioner(s) (LIP) and discussing the situation with them. Before you initiate this discussion, gather some additional information. If fluids are infusing, what is the patient’s ability to eat and drink? Are vital signs normal and stable? What medications are being given? What is the anticipated length of time remaining on this plan of care? If only a few more days, a change to oral medication may be possible.
Next assess where the catheter is located and how well it is functioning. Is the catheter tip in the recommended position in the lower SVC near or at the cavoatrial junction? Is the catheter functioning with a good blood return and no resistance to fluid flow through the catheter? If the catheter is correctly positioned and there is a blood return and there is no resistance to flushing or fluid infusion, this strongly favors leaving the catheter in place.
Next consider all systemic signs and symptoms the patient may have. Are there any signs or symptoms, concern or thoughts of bloodstream infection being present? If yes, this could mean an infected thrombus and will usually mean catheter removal. Is the patient complaining of pain or any type of excessive discomfort in the arm, neck, shoulder, or chest, especially on the ipsilateral side of the catheter? These complaints may mean it is more than the patient is able to tolerate, however treatment may help to improve those complaints.
Immediate removal when there is a need for another CVAD insertion may not be the best option. The next catheter could easily produce a similar event on the other side, so the goal is usually to leave it in place. The patient should be treated for DVT with systemic anticoagulation for as long as the CVAD is needed and for 3 months after it is removed.
Information about this is found in two INS Standards - Standard 52 CVAD Associated Thrombosis and Standard 44 VAD Removal. The medical references are two evidence based guidelines. You might want to find these and share with colleagues and appropriate committees in your facility.
Both of these publications can be downloaded free of charge. Click below to get the full text.
Kearon, C., Akl, E. A., Comerota, A. J., Prandoni, P., Bounameaux, H., Goldhaber, S. Z., . . . Dentali, F. (2012). Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines. CHEST Journal, 141(2_suppl), e419S-e494S.
Debourdeau, P., Farge, D., Beckers, M., Baglin, C., Bauersachs, R. M., Brenner, B., . . . Bounameaux, H. (2013). International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer. J Thromb Haemost, 11(1), 71-80. doi:10.1111/jth.12071